EN
HI
Glaxosmithkline Pharmaceuticals Chart
Glaxosmithkline Pharmaceuticals Share Key Metrics
Volume
54934.00
Market Cap
39529.20 CR
LTQ@LTP
1@2333.40
ATP
2333.76
Var Margin
16.47 %
Circuit Range
1877.3-2815.9
Delivery %
48.62 %
Value
12.82 CR
ASM/GSM
No
Market Lot
1
Summary
At 7 Apr, 2026 | 15:54, Glaxosmithkline Pharmaceuticals share price stands at ₹2333.4, showing a 13.20% -0.56 for the day. The stock’s intraday movement has stayed between ₹2315.20 and ₹2357.90, while on a 52-week basis it has fluctuated from ₹2217.60 to ₹3515.70.
In terms of trading activity, Glaxosmithkline Pharmaceuticals has recorded a volume of 54934 shares, with a market capitalisation of ₹169406034. The stock’s Average Traded Price (ATP) stands at ₹233376, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 1,233340. The stock operates within a circuit range of ₹1877.3-2815.9, with a Value of ₹12.82 CR. The Delivery Percentage for the day is 48.62%. Additionally, Glaxosmithkline Pharmaceuticals currently falls under the No framework, and trades with a market lot size of 1.
Glaxosmithkline Pharmaceuticals Fundamentals
View MoreP/E Ratio
38.94
P/B Ratio
19.84
Div. Yield
2.3
Sector P/E
60.49
Sector P/B
3.32
Sec. Div. Yield
0.59
Glaxosmithkline Pharmaceuticals Resistance and Support
Pivot 2323.43
Resistance
First Resistance
2379.06
Second Resistance
2411.53
Third Resistance
2467.16
Support
First Support
2290.96
Second Support
2235.33
Third Support
2202.86
Glaxosmithkline Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-02-09 | Quarterly Results |
| 2025-11-06 | Quarterly Results |
| 2025-08-01 | Quarterly Results |
| 2025-05-13 | Audited Results & Final Dividend |
| 2025-02-14 | Quarterly Results |
| 2025-02-10 | Quarterly Results |
Glaxosmithkline Pharmaceuticals News
GlaxoSmithKline Pharmaceuticals Limited
GlaxoSmithKline Pharmaceuticals received a ₹2.01 crore TDS demand liability from the tax authorities for AY 2020-2021. The company is contesting this assessment order, stating no financial impact on its statements.
Mar 31 2026 17:03:00
GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Disclosure Under Regulation 30
GlaxoSmithKline Pharmaceuticals received a final order from the TDS Authority for a demand liability of ₹2.01 crores for AY 2020-2021. The company is contesting the assessment order and states there is no impact on its financial statements.
Mar 31 2026 16:03:00
Read More
About Glaxosmithkline Pharmaceuticals
NSE : 1153
BSE : 500660
ISIN : INE159A01016
Glaxosmithkline Pharmaceuticals Management
| Name | Position |
|---|---|
| Ms. R S Karnad | Chairperson |
| Mr. B Akshikar | Managing Director |
Glaxosmithkline Pharmaceuticals Similar Stocks
Glenmark Pharmaceuticals Ltd.
2114.10
9.30 (0.44%)
Biocon Ltd.
340.05
-14.95 (4.21%)
Laurus Labs Ltd.
1057.45
-0.75 (0.07%)
Abbott India Ltd.
25665.00
-230.00 (0.89%)
Ipca Laboratories Ltd.
1442.20
-13.80 (0.95%)
Anthem Biosciences Ltd.
667.20
3.75 (0.57%)
Ajanta Pharma Ltd.
2711.60
-30.70 (1.12%)
Aster DM Healthcare Ltd.
655.75
-14.85 (2.21%)
Narayana Hrudayalaya Ltd.
1700.00
14.10 (0.84%)
Glaxosmithkline Pharmaceuticals FAQs
The Buying Price of Glaxosmithkline Pharmaceuticals share is 2333.4 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Glaxosmithkline Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Glaxosmithkline Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Glaxosmithkline Pharmaceuticals shares is 38.94. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Glaxosmithkline Pharmaceuticals shares is 19.84. Useful to assess the stock's value relative to its book value.
To assess Glaxosmithkline Pharmaceuticals’s valuation compare Sector P/E, P/B which are 60.49 & 3.32 with sector averages, along with growth rates and financial metrics.
The Market Cap of Glaxosmithkline Pharmaceuticals is 39529.20 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Glaxosmithkline Pharmaceuticals share price is 3515.70 & 2217.60. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Glaxosmithkline Pharmaceuticals belongs to the Healthcare sector.
